What is the equity of Takara Bio this year?
Takara Bio has equity of 111.51 B JPY this year.
Takara Bio Equity 2024
Takara Bio Equity
111.51 B JPY
Ticker
4974.T
ISIN
JP3460200003
WKN
A0DNGL
In 2024, Takara Bio's equity was 111.51 B JPY, a 16.3% increase from the 95.87 B JPY equity in the previous year.
Takara Bio Aktienanalyse
What does Takara Bio do?
Takara Bio Inc is a Japanese biotechnology company that has been active in the medical and life science industry since its founding in 1967. The company is a strong player in the field of molecular biology and operates in several countries such as the USA, Europe, and Asia. Takara Bio Inc was established as an independent company in 1999, focusing exclusively on the production of molecular biology products. The company offers a wide range of products in the fields of research and diagnostics, including enzymes, PCR kits, vectors and plasmids, antibodies, proteins, and cell culture products. Takara Bio Inc is organized into two divisions: Life Science Research and Diagnostics. The Life Science Research division provides products and solutions for research and development in areas such as molecular biology, neuroscience, proteomics, and genomics. The Diagnostics division offers products and solutions for clinical diagnostics and drug development. Takara Bio Inc also specializes in the automation of molecular biology procedures and offers automated systems that can perform processes such as nucleic acid extraction, PCR, and sequencing. The company is committed to sustainability and environmental protection, adhering to strict environmental and quality standards in its production processes and implementing waste reduction and efficient resource utilization programs. Overall, Takara Bio Inc is a leading company in the field of molecular biology, offering a wide range of products and solutions for research and diagnostics, and has become a key player in the life science industry through its global expansion and ability to provide custom solutions. Takara Bio ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Takara Bio's Equity
Takara Bio's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Takara Bio's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Takara Bio's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Takara Bio's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Takara Bio’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Takara Bio stock
What was the equity of Takara Bio compared to the previous year?
The equity of Takara Bio has increased/decreased by 16.3% increased compared to the previous year.
What impact does a high equity have on investors of Takara Bio?
A high equity is advantageous for investors of Takara Bio as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Takara Bio?
A low equity can be a risk for investors of Takara Bio, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Takara Bio affect the company?
An increase in equity of Takara Bio can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Takara Bio affect the company?
A reduction in equity of Takara Bio can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Takara Bio?
Some factors that can affect the equity of Takara Bio include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Takara Bio so important for investors?
The equity of Takara Bio is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Takara Bio take to change the equity?
To change equity, Takara Bio can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Takara Bio pay?
Over the past 12 months, Takara Bio paid a dividend of 17 JPY . This corresponds to a dividend yield of about 1.64 %. For the coming 12 months, Takara Bio is expected to pay a dividend of 19.79 JPY.
What is the dividend yield of Takara Bio?
The current dividend yield of Takara Bio is 1.64 %.
When does Takara Bio pay dividends?
Takara Bio pays a quarterly dividend. This is distributed in the months of April, April, April, April.
How secure is the dividend of Takara Bio?
Takara Bio paid dividends every year for the past 16 years.
What is the dividend of Takara Bio?
For the upcoming 12 months, dividends amounting to 19.79 JPY are expected. This corresponds to a dividend yield of 1.9 %.
In which sector is Takara Bio located?
Takara Bio is assigned to the 'Health' sector.
Wann musste ich die Aktien von Takara Bio kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Takara Bio from 6/1/2024 amounting to 17 JPY, you needed to have the stock in your portfolio before the ex-date on 3/28/2024.
When did Takara Bio pay the last dividend?
The last dividend was paid out on 6/1/2024.
What was the dividend of Takara Bio in the year 2023?
In the year 2023, Takara Bio distributed 42 JPY as dividends.
In which currency does Takara Bio pay out the dividend?
The dividends of Takara Bio are distributed in JPY.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Takara Bio
Our stock analysis for Takara Bio Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Takara Bio Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
